Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F

Immunity

Volumn 7, Issue 5, 1997, Pages 679-689

  Brennan, Paul ^a   Babbage, Jane W ^a   Burgering, Boudewijn M T ^b   Groner, Bernd ^c   Reif, Karin ^a   Cantrell, Doreen A ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b UTRECHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; CYCLINE; ENZYME INHIBITOR; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; REGULATOR PROTEIN; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F;

ARTICLE; CELL CYCLE; DNA SYNTHESIS; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LYMPHOCYTE CULTURE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 0031433335     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80388-X     Document Type: Article

References (63)

1. Abraham, R.T., and Wiederrecht, G.J. (1996). Immunopharmacology of rapamycin. Annu. Rev. Immunol. 14, 483-510.
2. Ahmed, N.N., Leighton Grimes, H., Bellacosa, A., Chan, T.O., and Tsichlis, P.N. (1997). Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase. Proc. Natl. Acad. Sci. USA 94, 3627-3632.
3. Alessi, D., Cuenda, A., Cohen, P., Dudlet, D., and Saltiel, A. (1995). PD098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270, 27489-27494.
4. Bartek, J., Bartkova, J., and Lukas, J. (1996). The retinoblastoma protein pathway and the restriction point. Curr. Opin. Curr. Biol. 8, 805-814.
5. Beadling, C., Guschin, D., Witthuhn, B.A., Ziemiecki, A., Ihle, J.N., Kerr, I.M., and Cantrell, D.A. (1994). Activation of JAK kinases and STAT proteins by interleukin-2 and interferon-α, but not the T cell antigen receptor, in human T lymphocytes. EMBO J. 13, 5605-5615.
6. Beadling, C., Ng, J., Babbage, J.W., and Cantrell, D.A. (1996). Interleukin-2 activation of STATS requires the convergent action of tyrosine kinases and a serine/threonine kinase distinct from the Raf-1/Erk2 MAP kinase pathway. EMBO J. 15, 1902-1913.
7. Botz, J., Zerfass-Thome, K., Spitzovsky, D., Delius, H., Vogt, B., Eilers, M., Hatzigeorgiou, A., and Jansen-Durr, P. (1996). Cell cycle regulation of the murine cyclin E gene depends on an E2F binding site in the promoter. Mol. Cell. Biol. 16, 3401-3409.
8. Burgering, B.M., and Coffer, P.J. (1995). Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376, 599-602.
9. Chittenden, T., Livingston, D.M., and DeCaprio, J.A. (1993). Cell cycle analysis of E2F in primary human T cells reveals novel E2F complexes and biochemically distinct forms of free E2F. Mol. Cell. Biol. 13, 3975-3983.
10. Corcoran, A.E., Smart, F.M., Cowling, R.J., Crompton, T., Owen, M.J., and Venkitaraman, A.R. (1996). The interleukin-7 receptor alpha chain transmits distinct signals for proliferation and differentiation during B lymphopoiesis. EMBO J. 15, 1924-1932.
11. Dhand, R., Hara, K., Hiles, I., Bax, B., Gout, I., Panayotou, G., Fry, M.J., Yonezawa, K., Kasuga, M., and Waterfield, M.D. (1994). PI 3-kinase: structural and functional analysis of intersubunit interactions. EMBO J. 13, 511-521.
12. Fairhurst, R.M., Daeipour, M., Amaral, M.C., and Nel, A.E. (1993). Activation of mitogen-activated protein kinase/ERK-2 in phytohaemagglutin in blasts by recombinant interleukin-2: contrasting features with CD3 activation. Immunology 79, 112-118.
13. Field, S.J., Tsai, F.Y., Kuo, F., Zubiaga, A.M., Kaelin, W.G., Jr., Livingston, D.M., Orkin, S.H., and Greenberg, M.E. (1996). E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 85, 549-561.
14. Frevert, E.U., and Kahn, B.B. (1997). Differential effects of constitutively active phosphatidylinositol 3-kinase on glucose transport, glycogen synthase activity and DNA synthesis in 3T3-L1 adipocytes. Mol. Cell. Biol. 17, 190-198.
15. Friedmann, M.C., Migone, T.-S., Russell, S.M., and Leonard, W.J. (1996). Different interleukin 2 receptor B-chain tyrosines couple to at least two signaling pathways and synergistically mediate interleukin 2-induced proliferation. Proc. Natl. Acad. Sci. USA 93, 2077-2082.
16. Gaffen, S.L., Lai, S.Y., Ha, M., Liu, X., Hennighausen, L., Greene, W.C., and Goldsmith, M.A. (1996). Distinct tyrosine residues within the interleukin-2 receptor beta chain drive signal transduction specificity, redundancy, and diversity. J. Biol. Chem. 271, 21381-21390.
17. Genot, E.M., Parker, P.J., and Cantrell, D.A. (1995). Analysis of the role of the protein kinase Ca,e,z in T cell activation. J. Biol. Chem. 270, 9833-9839.
18. Gille, H., Strahl, T., and Shaw, P.E. (1995). Activation of ternary complex factor elk-1 by stress-activated protein kinases. Curr. Biol. 5, 1191-1200.
19. Graves, J.D., Downward, J., Izquierdo, M., Rayter, S., Warne, P.H., and Cantrell, D.A. (1992). The growth factor interleukin-2 activates p21ras proteins in normal human T lymphocytes. J. Immunol. 148, 2417-2422.
20. Hamel, P.A., Gill, R.M., Phillips, R.A., and Gallie, B.L. (1992). Regions controlling hyperphosphorylation and conformation of the retino-blastoma gene product are independent of domains required for transcriptional repression. Oncogene 7, 693-701.
21. Hori, T., Uchiyama, T., Tsudo, M., Umadome, H., Ohno, H., Fukuhara, S., Kita, K., and Uchino, H. (1987). Establishment of an interleukin-2-dependent human T cell line from a patient with T cell chronic lymphocytic leukemia who is not infected with human T cell leukemia/lymphoma virus. Blood 70, 1069-1072.
22. Hou, J., Schindler, U., Henzel, W.J., Wong, S.C., and McKnight, S.L. (1995). Identification and purification of human Stat proteins activated in response to interleukin-2. Immunity 2, 321-329.
23. Izquierdo Pastor, M., Reif, K., and Cantrell, D. (1995). The regulation and function of p21 ras during T-cell activation and growth. Immunol. Today 16, 159-164.
24. Johnston, J., Kawamura, M., Kirken, R., Chen, Y., Blake, T., Shibuya, K., Ortaldo, J., McVicar, D., and O'Shea, J. (1994). Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2. Nature 370, 151-153.
25. Johnston, J.A., Bacon, C.M., Finbloom, D.S., Rees, R.C., Kaplan, D., Shibuya, K., Ortaldo, J.R., Gupta, S., Chen, Y.Q., Giri, J.D., et al. (1995). Tyrosine phosphorylation and activation of Stat5, Stat3, and Janus kinases by interleukin-2 and interleukin-15. Proc. Natl. Acad. Sci. USA 92, 8705-8709.
26. Kaplan, M., Schindler, U., Smiley, S., and Grusby, M. (1996a). Stat6 is required for mediating responses to IL-4 and for the development of Th2 cells. Immunity 4, 313-319.
27. Kaplan, M.H., Sun, Y.L., Hoey, T., and Grusby, M.J. (1996b). Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 382, 174-177.
28. Karnitz, L.M., Burns, L.A., Sutor, S.L., Blenis, J., and Abraham, R.T. (1995). Interleukin-2 triggers a novel phosphatidylinositol 3-kinase-dependent MEK activation pathway. Mol. Cell. Biol. 15, 3049-3057.
29. Kauffmann-Zeh, A., Rodriguez-Viciana, P., Ulrich, E., Gilbert, C., Coffer, P., Downward, J., and Evan, G. (1997). Supression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature 385, 544-548.
30. Lin, J.-X., Migone, T.-S., Tsang, M., Friedmann, M., Weatherbee, J.A., Zhou, L., Yamauchi, A., Bloom, E.T., Mietz, J., John, S., et al. (1995). The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity 2, 331-339.
31. Loeken, M.R., and Brady, J. (1989). The adenovirus EIIA enhancer. Analysis of regulatory sequences and changes in binding activity of ATF and EIIF following adenovirus infection. J. Biol. Chem. 264, 6572-6579.
32. Mann, D.J., and Jones, N.C. (1996). E2F-1 but not E2F-4 can overcome p16-induced G1 cell-cycle arrest. Curr. Biol. 6, 474-483.
33. Marais, R., Wynne, J., and Treisman, R. (1993). The SRF accesory protein Elk-1 contains a growth factor-regulated transcriptional activation domain. Cell 73, 381-393.
34. Minami, Y., Nakagawa, Y., Kawahara, A., Miyazaki, T., Sada, K., Yamamura, H., and Taniguchi, T. (1995). Protein tyrosine kinase Syk is associated with and activated by the IL-2 receptor: possible link with the c-myc induction pathway. Immunity 2, 89-100.
35. Miyazaki, T., Kawahara, A., Fujii, H., Nakagawa, Y., Minami, Y., Liu, Z.-J., Oishi, I., Silvennoinen, O., Witthuhn, B., Ihle, J., et al. (1994). Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits. Science 266, 1045-1047.
36. Miyazaki, T., Liu, Z.J., Kawahara, A., Minami, Y., Yamada, K., Tsujimoto, Y., Barsoumian, E.L., Permutter, R.M., and Taniguchi, T. (1995). Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation. Cell 81, 223-231.
37. Moberg, K., Starz, M.A., and Lees, J.A. (1996). E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry. Mol. Cell. Biol. 16, 1436-1449.
38. Modiano, J.F., Domenico, J., Szepesi, A., Lucas, J.J., and Gelfand, E.W. (1994). Differential requirements for interleukin-2 distinguish the expression and activity of the cyclin-dependent kinases Cdk4 and Cdk2 in human T cells. J. Biol. Chem. 269, 32972-32978.
39. Morice, W.G., Wiederrecht, G., Brunn, G.J., Siekierka, J.J., and Abraham, R.T. (1993). Rapamycin inhibition of interleukin-2-dependent p33cdk2 and p34cdc2 kinase activation in T lymphocytes. J. Biol. Chem. 268, 22737-22745.
40. Moriggl, R., Gouilleux-Gruart, G., Jahne, R., Berchtold, S., Gartmann, C., Liu, X., Hennighausen, L., Sotiropoulos, A., Groner, B., and Gouilleux, F. (1996). Deletion of the carboxyl-terminal transactivation domain of MGF-Stat5 results in sustained DNA binding and adominant negative phenotype. Mol. Cell. Biol. 16, 5691-5700.
41. Mui, A.L.-F., Wakao, H., Kinoshita, T., Katamura, T., and Miyajima, A. (1996). Supression of interleukin-3-induced gene expression by a C-terminal truncated Stat5: role of Stat5 in proliferation. EMBO J. 15, 2425-2433.
42. Murthy, S.C., Bhat, G.P., and Thimmappaya, B. (1985). Adenovirus EIIA early promoter: transcriptional control elements and induction by the viral pre-early EIA gene, which appears to be sequence independent. Proc. Natl. Acad. Sci. USA 82, 2230-2234.
43. Nourse, J., Firpo, E., Flanagan, W.M., Coats, S., Polyak, K., Lee, M.H., Massague, J., Crabtree, G.R., and Roberts, J.M. (1994). Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372, 570-573.
44. Ohtani, K., and Nevins, J.R. (1994). Functional properties of a Drosophila homolog of the E2F1 gene. Mol. Cell. Biol. 14, 1603-1612.
45. Panayotou, G., and Waterfield, M.D. (1992). Phosphatidylinositol 3-kinase: a key enzyme in diverse signalling processes. Trends Cell Biol. 2, 358-360.
46. Reif, K., Nobes, C.D., Thomas, G., Hall, A., and Cantrell, D.A. (1996). Phosphatidylinositol 3-kinase signals activate a selective subset of Rac/Rho-dependent effector pathways. Curr. Biol. 6, 1445-1455.
47. Reif, K., Burgering, B.M.T., and Cantrell, D.A. (1997). Phosphatidylinositol 3-kinase links the interleukin-2 receptor to protein kinase B and p70 S6 kinase. J. Biol. Chem. 272, 14426-14438.
48. Roche, S., Koegl, M., and Courtneidge, S.A. (1994). The phosphatidylinositol 3-kinase a is required for DNA synthesis induced by some, but not all, growth factors. Proc. Natl. Acad. Sci. USA 91, 9185-9189.
49. Russell, S., Johnston, J., Noguchi, M., Kawamura, M., Bacon, C., Friedman, M., Berg, M., McVicar, D., Witthuhn, B., Silvennoinen, O., et al., (1994). Interaction of IL-2β β and γ chains with Jak1 and Jak3: implications for XSCID and XCID. Science 266, 1042-1045.
50. Satoh, T., Nakafuku, M., Miyajima, A.,and Kaziro, Y. (1991). Involvement of p21 ras in signal transduction pathways from interleukin 2, interleukin 3 and granulocyte/macrophagecolony stimulating factor, but not from interleukin 4. Proc. Natl. Acad. Sci. USA 88, 3314-3318.
51. Sherr, C.J. (1996). Cancer cell cycles. Science 274, 1672-1677.
52. Shimoda, K., Vandeursen, J., Sangster, M.Y., Sarawar, S.R., Carson, R.T., Tripp, R.A., Chu, C., Quelle, F.W., Nosaka, T., Vignali, D.A.A., et al. (1996). Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted state gene. Nature 380, 630-633.
53. Slansky, J.E., and Farnham, P.J. (1996). Transcriptional regulation of the dihydrofolate reductase gene. BioEssays 18, 55-62.
54. Smith, K.A. (1988). Interleukin-2: Inception, impact and implications. Science 240, 1169-1176.
55. Taniguchi, T. (1995). Cytokine signaling through nonreceptor protein tyrosine kinases. Science 268, 251-255.
56. Thierfelder, W.E., van Deursen, J.M., Yamamoto, K., Tripp, R.A., Sarawar, S.R., Carson, R.T., Sangster, M.Y., Vignali, D.A., Doherty, P.C., Grosveld, G.C., et al. (1996). Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 382, 171-174.
57. Turner, B., Rapp, U., App, H., Greene, M., Dobashi, K., and Reid, J. (1991). lnterleukin-2 induces tyrosine phosphorylation and activation of p72-74 Raf-1 kinase in a T cell line. Proc. Natl. Acad. Sci. USA 88, 1227-1232.
58. Turner, J.M. (1993). IL-2-dependent induction of G1 cyclins in primary T cells is not blocked by rapamycin or cyclosporin A. Int. Immunol. 5, 1199-1209.
59. Von Manteuffel, S.R., Gingras, A.C., Ming, X.F., Sonenberg, N., and Thomas, G. (1996). 4E-BP1 phosphorylation is mediated by the Frap-p70 S6 kinase pathway and is independent of mitogen-activated protein-kinase. Proc. Natl. Acad. Sci. USA 93, 4076-4080.
60. Williams, D.H., Woodrow, M., Cantrell, A.D., and Murray, J.E. (1995). Protein kinase C is not a downstream effector of p21 ras in activated T cell. Eur. J. Immunol. 25, 42-47.
61. Witthuhn, B., Silvennoinen, O., Miura, O., Lai, K., Cwik, C., Liu, E., and Ihle, J. (1994). Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells. Nature 370, 153-157.
62. Xu, G., Livingston, D.M., and Krek, M. (1995). Multiple members of the E2F transcription factor family are the products of oncogenes. Proc. Natl. Acad. Sci. USA 92, 1357-1361.
63. Yamasaki, L., Jacks, T., Bronson, R., Goillot, E., Harlow, E., and Dyson, N.J. (1996). Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 85, 537-548.